WT1 and Sox11 regulate synergistically the promoter of the Wnt4 gene that encodes a critical signal for nephrogenesis

Experimental Cell Research

Volumn 318, Issue 10, 2012, Pages 1134-1145

  Murugan, Subramanian ^a   Shan, Jingdong ^a   Kühl, Susanne J ^b   Tata, Aleksandra ^b   Pietilä, Ilkka ^a   Kühl, Michael ^b   Vainio, Seppo J ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Kidney cancer; Kidney development; Mesenchyme to epithelium transition; Sox11; Wilm's tumor; Wnt4 signaling

Indexed keywords

ANTIBODY; MORPHOLINE DERIVATIVE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX11; TRANSCRIPTION FACTOR WT1; UNCLASSIFIED DRUG; WNT PROTEIN; WNT4 PROTEIN; WT1 PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; KIDNEY CELL; KIDNEY DEVELOPMENT; KIDNEY TUBULE; MOUSE; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; ONTOGENY; PRIORITY JOURNAL; PROMOTER REGION; PRONEPHROS; PROTEIN FAMILY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOX11 GENE; WNT4 GENE; WT1 GENE; XENOPUS;

MAMMALIA;

EID: 84860384795     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.03.008     Document Type: Article

References (61)

1. Brandli A.W. Towards a molecular anatomy of the Xenopus pronephric kidney. Int. J. Dev. Biol. 1999, 43:381-395.
2. Vainio S., Lin Y. Coordinating early kidney development: lessons from gene targeting. Nat. Rev. Genet. 2002, 3:533-543.
3. Schedl A. Renal abnormalities and their developmental origin. Nat. Rev. Genet. 2007, 8:791-802.
4. Costantini F., Kopan R. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev. Cell 2010, 18:698-712.
5. Carroll T.J., Park J.S., Hayashi S., Majumdar A., McMahon A.P. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev. Cell 2005, 9:283-292.
6. Majumdar A., Vainio S., Kispert A., McMahon J., McMahon A.P. Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development. Development 2003, 130:3175-3185.
7. Stark K., Vainio S., Vassileva G., McMahon A.P. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by wnt-4. Nature 1994, 372:679-683.
8. Kispert A., Vainio S., McMahon A.P. Wnt-4 is a mesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney. Development 1998, 125:4225-4234.
9. Corbin M., de Reynies A., Rickman D.S., Berrebi D., Boccon-Gibod L., Cohen-Gogo S., Fabre M., Jaubert F., Faussillon M., Yilmaz F., Sarnacki S., Landman-Parker J., Patte C., Schleiermacher G., Antignac C., Jeanpierre C. WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries?. Genes Chromosomes Cancer 2009, 48:816-827.
10. Kim M.S., Yoon S.K., Bollig F., Kitagaki J., Hur W., Whye N.J., Wu Y.P., Rivera M.N., Park J.Y., Kim H.S., Malik K., Bell D.W., Englert C., Perantoni A.O., Lee S.B. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway. J. Biol. Chem. 2010, 285:14585-14593.
11. Moisan A., Rivera M.N., Lotinun S., Akhavanfard S., Coffman E.J., Cook E.B., Stoykova S., Mukherjee S., Schoonmaker J.A., Burger A., Kim W.J., Kronenberg H.M., Baron R., Haber D.A., Bardeesy N. The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification. Dev. Cell 2011, 20:583-596.
12. Rivera M.N., Haber D.A. Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat. Rev. Cancer 2005, 5:699-712.
13. Mrowka C., Schedl A. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features. J. Am. Soc. Nephrol. 2000, 11(Suppl. 16):S106-S115.
14. Kobayashi A., Valerius M.T., Mugford J.W., Carroll T.J., Self M., Oliver G., McMahon A.P. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 2008, 3:169-181.
15. Osada M., Park H.L., Nagakawa Y., Begum S., Yamashita K., Wu G., Kim M.S., Trink B., Sidransky D. A novel response element confers p63- and p73-specific activation of the WNT4 promoter. Biochem. Biophys. Res. Commun. 2006, 339:1120-1128.
16. Torban E., Dziarmaga A., Iglesias D., Chu L.L., Vassilieva T., Little M., Eccles M., Discenza M., Pelletier J., Goodyer P. PAX2 activates WNT4 expression during mammalian kidney development. J. Biol. Chem. 2006, 281:12705-12712.
17. Davies J.A., Ladomery M., Hohenstein P., Michael L., Shafe A., Spraggon L., Hastie N. Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation. Hum. Mol. Genet. 2004, 13:235-246.
18. Kreidberg J.A., Sariola H., Loring J.M., Maeda M., Pelletier J., Housman D., Jaenisch R. WT-1 is required for early kidney development. Cell 1993, 74:679-691.
19. Essafi A., Webb A., Berry R.L., Slight J., Burn S.F., Spraggon L., Velecela V., Martinez-Estrada O.M., Wiltshire J.H., Roberts S.G., Brownstein D., Davies J.A., Hastie N.D., Hohenstein P. A wt1-controlled chromatin switching mechanism underpins tissue-specific wnt4 activation and repression. Dev. Cell 2011, 21:559-574.
20. Devgan V., Mammucari C., Millar S.E., Brisken C., Dotto G.P. p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev. 2005, 19:1485-1495.
21. Zhang H., Singh R.R., Talukder A.H., Kumar R. Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway. Genes Dev. 2006, 20:2943-2948.
22. Davies J.A., Garrod D.R. Induction of early stages of kidney tubule differentiation by lithium ions. Dev. Biol. 1995, 167:50-60.
23. Mendelsohn C., Lohnes D., Decimo D., Lufkin T., LeMeur M., Chambon P., Mark M. Function of the retinoic acid receptors (RARs) during development (II). multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 1994, 120:2749-2771.
24. Dudley A.T., Godin R.E., Robertson E.J. Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes Dev. 1999, 13:1601-1613.
25. Valerius M.T., Patterson L.T., Witte D.P., Potter S.S. Microarray analysis of novel cell lines representing two stages of metanephric mesenchyme differentiation. Mech. Dev. 2002, 112:219-232.
26. Reddy J.C., Morris J.C., Wang J., English M.A., Haber D.A., Shi Y., Licht J.D. WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J. Biol. Chem. 1995, 270:10878-10884.
27. English M.A., Licht J.D. Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control. J. Biol. Chem. 1999, 274:13258-13263.
28. Nieuwkoop P., Faber J. External and Internal Stage Criteria in the Development of Xenopus laevis 1975, Elsevier, Amsterdam.
29. Moody S.A., Kline M.J. Segregation of fate during cleavage of frog (Xenopus laevis) blastomeres. Anat. Embryol. (Berl) 1990, 182:347-362.
30. Tecza A., Bugner V., Kuhl M., Kuhl S.J. Pescadillo homologue 1 and peter pan function during Xenopus laevis pronephros development. Biol. Cell 2011, 103:483-498.
31. Gessert S., Maurus D., Kuhl M. Repulsive guidance molecule A (RGM A) and its receptor neogenin during neural and neural crest cell development of Xenopus laevis. Biol. Cell 2008, 100:659-673.
32. Gavin B.J., McMahon J.A., McMahon A.P. Expression of multiple novel wnt-1/int-1-related genes during fetal and adult mouse development. Genes Dev. 1990, 4:2319-2332.
33. Cui S., Schwartz L., Quaggin S.E. Pod1 is required in stromal cells for glomerulogenesis. Dev. Dyn. 2003, 226:512-522.
34. Quaggin S.E., Schwartz L., Cui S., Igarashi P., Deimling J., Post M., Rossant J. The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 1999, 126:5771-5783.
35. Sock E., Rettig S.D., Enderich J., Bosl M.R., Tamm E.R., Wegner M. Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling. Mol. Cell. Biol. 2004, 24:6635-6644.
36. Patel S.R., Dressler G.R. Expression of Pax2 in the intermediate mesoderm is regulated by YY1. Dev. Biol. 2004, 267:505-516.
37. Plisov S.Y., Ivanov S.V., Yoshino K., Dove L.F., Plisova T.M., Higinbotham K.G., Karavanova I., Lerman M., Perantoni A.O. Mesenchymal-epithelial transition in the developing metanephric kidney: gene expression study by differential display. Genesis 2000, 27:22-31.
38. Kiemer A.K., Takeuchi K., Quinlan M.P. Identification of genes involved in epithelial-mesenchymal transition and tumor progression. Oncogene 2001, 20:6679-6688.
39. Carroll T.J., Wallingford J.B., Vize P.D. Dynamic patterns of gene expression in the developing pronephros of Xenopus laevis. Dev. Genet. 1999, 24:199-207.
40. Saulnier D.M., Ghanbari H., Brandli A.W. Essential function of wnt-4 for tubulogenesis in the Xenopus pronephric kidney. Dev. Biol. 2002, 248:13-28.
41. Hargrave M., Wright E., Kun J., Emery J., Cooper L., Koopman P. Expression of the Sox11 gene in mouse embryos suggests roles in neuronal maturation and epithelio-mesenchymal induction. Dev. Dyn. 1997, 210:79-86.
42. Georgas K., Rumballe B., Wilkinson L., Chiu H.S., Lesieur E., Gilbert T., Little M.H. Use of dual section mRNA in situ hybridisation/immunohistochemistry to clarify gene expression patterns during the early stages of nephron development in the embryo and in the mature nephron of the adult mouse kidney. Histochem. Cell Biol. 2008, 130:927-942.
43. Mugford J.W., Yu J., Kobayashi A., McMahon A.P. High-resolution gene expression analysis of the developing mouse kidney defines novel cellular compartments within the nephron progenitor population. Dev. Biol. 2009, 333:312-323.
44. Sim E.U., Smith A., Szilagi E., Rae F., Ioannou P., Lindsay M.H., Little M.H. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. Oncogene 2002, 21:2948-2960.
45. Rae F.K., Martinez G., Gillinder K.R., Smith A., Shooter G., Forrest A.R., Grimmond S.M., Little M.H. Analysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1. Oncogene 2004, 23:3067-3079.
46. Englert C., Maheswaran S., Garvin A.J., Kreidberg J., Haber D.A. Induction of p21 by the Wilms' tumor suppressor gene WT1. Cancer Res. 1997, 57:1429-1434.
47. Mazzei L., Garcia I.M., Cacciamani V., Benardon M.E., Manucha W. WT-1 mRNA expression is modulated by nitric oxide availability and Hsp70 interaction after neonatal unilateral ureteral obstruction. Biocell 2010, 34:121-132.
48. Maheswaran S., Englert C., Zheng G., Lee S.B., Wong J., Harkin D.P., Bean J., Ezzell R., Garvin A.J., McCluskey R.T., DeCaprio J.A., Haber D.A. Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70. Genes Dev. 1998, 12:1108-1120.
49. Reginensi A., Clarkson M., Neirijnck Y., Lu B., Ohyama T., Groves A.K., Sock E., Wegner M., Costantini F., Chaboissier M.C., Schedl A. SOX9 controls epithelial branching by activating RET effector genes during kidney development. Hum. Mol. Genet. 2011, 20:1143-1153.
50. Hartwig S., Ho J., Pandey P., Macisaac K., Taglienti M., Xiang M., Alterovitz G., Ramoni M., Fraenkel E., Kreidberg J.A. Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development. Development 2010, 137:1189-1203.
51. Dy P., Penzo-Mendez A., Wang H., Pedraza C.E., Macklin W.B., Lefebvre V. The three SoxC proteins-Sox4, Sox11 and Sox12-exhibit overlapping expression patterns and molecular properties. Nucleic Acids Res. 2008, 36:3101-3117.
52. Sinner D., Kordich J.J., Spence J.R., Opoka R., Rankin S., Lin S.C., Jonatan D., Zorn A.M., Wells J.M. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol. Cell. Biol. 2007, 27:7802-7815.
53. Sharma P.M., Bowman M., Yu B.F., Sukumar S. A rodent model for Wilms tumors: embryonal kidney neoplasms induced by N-nitroso-N'-methylurea. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:9931-9935.
54. Kim M.K., McGarry T.J., Broin P.O., Flatow J.M., Golden A.A., Licht J.D. An integrated genome screen identifies the wnt signaling pathway as a major target of WT1. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:11154-11159.
55. Shan J., Jokela T., Skovorodkin I., Vainio S. Mapping of the fate of cell lineages generated from cells that express the Wnt4 gene by time-lapse during kidney development. Differentiation 2010, 79:57-64.
56. Cook D.M., Hinkes M.T., Bernfield M., Rauscher F.J. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1. Oncogene 1996, 13:1789-1799.
57. Han Y., San-Marina S., Liu J., Minden M.D. Transcriptional activation of c-myc proto-oncogene by WT1 protein. Oncogene 2004, 23:6933-6941.
58. Udtha M., Lee S.J., Alam R., Coombes K., Huff V. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors. Oncogene 2003, 22:3821-3826.
59. Zhang X., Xing G., Saunders G.F. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1. Anticancer. Res. 1999, 19:1641-1648.
60. Vainio S., Jalkanen M., Bernfield M., Saxen L. Transient expression of syndecan in mesenchymal cell aggregates of the embryonic kidney. Dev. Biol. 1992, 152:221-232.
61. Vainio S., Lehtonen E., Jalkanen M., Bernfield M., Saxen L. Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev. Biol. 1989, 134:382-391.